Web Version

30% OFF* Swift Amplicon SARS-CoV-2 Panel

  • SARS-CoV-2 whole viral genome single-tube NGS assay
  • 341 amplicons sized 116-255 bp (average 150 bp)
  • 98% SARS-CoV-2 genome coverage (29,313 of 29,903 bases)
  • 2 hours cDNA-to-library processing time

The Swift Amplicon SARS-CoV-2 Panel offers a robust NGS workflow that provides optimal coverage and NGS data quality on Illumina sequencing platforms. This kit leverages patented multiplex PCR technology, enabling library construction from 1st-strand or 2nd-strand cDNA using tiled primer pairs to target the entire 29.9 kb viral genome with a single pool of multiplexed primer pairs. Primers were designed against the NCBI Reference Sequence NC_045512.2 (Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome). In silico analysis predicted zero off-target products from human host genome sequences.

SARS-CoV-2 Research Reagents Overview

*Expires 30 June 2020

BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: https://www.biocat.com